Neurodegenerative diseases: Might citrus flavonoids play a protective role?

Molecules

Volumn 21, Issue 10, 2016, Pages

  Cirmi, Santa ^a   Ferlazzo, Nadia ^a   Lombardo, Giovanni E ^b   Ventura Spagnolo, Elvira ^c   Gangemi, Sebastiano ^d,e   Calapai, Gioacchino ^a   Navarra, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

^e CNR   (Italy)

Author keywords

Citrus; Flavonoids; Neurodegeneration; Neurodegenerative disorders; Nutraceutical

Indexed keywords

FLAVONOID; NEUROPROTECTIVE AGENT;

CHEMISTRY; CITRUS; FRUIT; HUMAN; NEURODEGENERATIVE DISEASES;

CITRUS; FLAVONOIDS; FRUIT; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS;

EID: 84992391451     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21101312     Document Type: Review

References (165)

1. Perez-Hernandez, J.; Zaldivar-Machorro, V.J.; Villanueva-Porras, D.; Vega-Avila, E.; Chavarria, A. A potential alternative against neurodegenerative diseases: Phytodrugs. Oxid. Med. Cell. Longev. 2016, 2016, 8378613. [CrossRef,PubMed].
2. Solanki, L.; Parihar, P.; Mansuri, M.L.; Parihar, M.S. Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv. Nutr. 2015, 6, 64-72. [CrossRef,PubMed].
3. Hwang, S.L.; Shih, P.H.; Yen, G.C. Neuroprotective effects of Citrus flavonoids. J. Agric. Food Chem. 2012, 60, 877-885. [CrossRef,PubMed].
4. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747. [PubMed].
5. Middleton, E. Jr.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751. [PubMed].
6. Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013, 2013, 162750. [CrossRef,PubMed].
7. Yao, L.H.; Jiang, Y.M.; Shi, J.; Tomas-Barberan, F.A.; Datta, N.; Singanusong, R.; Chen, S.S. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. 2004, 59, 113-122. [CrossRef,PubMed].
8. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of Citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185-6205. [CrossRef,PubMed].
9. Curro, M.; Risitano, R.; Ferlazzo, N.; Cirmi, S.; Gangemi, C.; Caccamo, D.; Ientile, R.; Navarra, M. Citrus bergamia juice extract attenuates β-Amyloid-induced pro-inflammatory activation of thp-1 cells through mapk and ap-1 pathways. Sci. Rep. 2016, 6, 20809. [CrossRef,PubMed].
10. Ferlazzo, N.; Visalli, G.; Smeriglio, A.; Cirmi, S.; Lombardo, G.E.; Campiglia, P.; Di Pietro, A.; Navarra, M. Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress. Evid. Based Complement. Altern. Med. 2015, 2015, 957031. [CrossRef,PubMed].
11. Ferlazzo, N.; Cirmi, S.; Russo, M.; Trapasso, E.; Ursino, M.R.; Lombardo, G.E.; Gangemi, S.; Calapai, G.; Navarra, M. NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci. 2016, 146, 81-91. [CrossRef,PubMed].
12. Ferlazzo, N.; Visalli, G.; Cirmi, S.; Lombardo, G.E.; Lagana, P.; di Pietro, A.; Navarra, M. Natural iron chelators: Protective role in A549 cells of flavonoids-rich extracts of Citrus juices in Fe3+-induced oxidative stress. Environ. Toxicol. Pharmacol. 2016, 43, 248-256. [CrossRef,PubMed].
13. Risitano, R.; Curro, M.; Cirmi, S.; Ferlazzo, N.; Campiglia, P.; Caccamo, D.; Ientile, R.; Navarra, M. Flavonoid fraction of bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PLoS ONE 2014, 9, e107431. [CrossRef,PubMed].
14. Visalli, G.; Ferlazzo, N.; Cirmi, S.; Campiglia, P.; Gangemi, S.; di Pietro, A.; Calapai, G.; Navarra, M. Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anti-Cancer Agents Med. Chem. 2014, 14, 1402-1413. [CrossRef].
15. Delle Monache, S.; Sanita, P.; Trapasso, E.; Ursino, M.R.; Dugo, P.; Russo, M.; Ferlazzo, N.; Calapai, G.; Angelucci, A.; Navarra, M. Mechanisms underlying the anti-Tumoral effects of Citrus bergamia juice. PLoS ONE 2013, 8, e61484. [CrossRef,PubMed].
16. Filocamo, A.; Bisignano, C.; Ferlazzo, N.; Cirmi, S.; Mandalari, G.; Navarra, M. In vitro effect of bergamot (Citrus bergamia) juice against caga-positive and-negative clinical isolates of helicobacter pylori. BMC Complement. Altern. Med. 2015, 15, 256. [CrossRef,PubMed].
17. Impellizzeri, D.; Bruschetta, G.; di Paola, R.; Ahmad, A.; Campolo, M.; Cuzzocrea, S.; Esposito, E.; Navarra, M. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin. Nutr. 2015, 34, 1146-1154. [CrossRef,PubMed].
18. Navarra, M.; Ursino, M.R.; Ferlazzo, N.; Russo, M.; Schumacher, U.; Valentiner, U. Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 2014, 95, 83-92. [CrossRef,PubMed].
19. Celano, M.; Maggisano, V.; de Rose, R.F.; Bulotta, S.; Maiuolo, J.; Navarra, M.; Russo, D. Flavonoid fraction of Citrus reticulata juice reduces proliferation and migration of anaplastic thyroid carcinoma cells. Nutr. Cancer 2015, 67, 1183-1190. [CrossRef,PubMed].
20. Marino, A.; Paterniti, I.; Cordaro, M.; Morabito, R.; Campolo, M.; Navarra, M.; Esposito, E.; Cuzzocrea, S. Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. PharmaNutrition 2015, 3, 53-59. [CrossRef].
21. Cirmi, S.; Bisignano, C.; Mandalari, G.; Navarra, M. Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: A systematic review. Phytother. Res. 2016, 30, 1404-1411. [CrossRef,PubMed].
22. Impellizzeri, D.; Cordaro, M.; Campolo, M.; Gugliandolo, E.; Esposito, E.; Benedetto, F.; Cuzzocrea, S.; Navarra, M. Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion injury. Front. Pharmacol. 2016, 30. [CrossRef,PubMed].
23. Ferlazzo, N.; Cirmi, S.; Calapai, G.; Ventura-Spagnolo, E.; Gangemi, S.; Navarra, M. Anti-inflammatory activity of Citrus bergamia derivatives: Where do we stand? Molecules 2016, 21, 1273. [CrossRef,PubMed].
24. Citraro, R.; Navarra, M.; Leo, A.; Donato di Paola, E.; Santangelo, E.; Lippiello, P.; Aiello, R.; Russo, E.; de Sarro, G. The anticonvulsant activity of a flavonoid-rich extract from orange juice involves both NMDA and GABA-benzodiazepine receptor complexes. Molecules 2016, 21, 1261. [CrossRef,PubMed].
25. Fratiglioni, L.; Launer, L.J.; Andersen, K.; Breteler, M.M.; Copeland, J.R.; Dartigues, J.F.; Lobo, A.; Martinez-Lage, J.; Soininen, H.; Hofman, A. Incidence of dementia and major subtypes in europe: A collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000, 54, S10-S15. [PubMed].
26. O'Brien, R.J.;Wong, P.C. Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 2011, 34, 185-204. [CrossRef,PubMed].
27. Sarkar, A.; Irwin, M.; Singh, A.; Riccetti, M.; Singh, A. Alzheimer's disease: The silver tsunami of the 21st century. Neural. Regen. Res. 2016, 11, 693-697. [PubMed].
28. Murphy, M.P.; LeVine, H. III. Alzheimer's disease and the amyloid-β peptide. J. Alzheimers Dis. 2010, 19, 311-323. [PubMed].
29. Hong, H.; Kim, B.S.; Im, H.I. Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int. Neurourol. J. 2016, 20, S2-S7. [CrossRef,PubMed].
30. Reeve, A.; Simcox, E.; Turnbull, D. Ageing and Parkinson's disease: Why is advancing age the biggest risk factor? Ageing Res. Rev. 2014, 14, 19-30. [CrossRef,PubMed].
31. Wirdefeldt, K.; Adami, H.O.; Cole, P.; Trichopoulos, D.; Mandel, J. Epidemiology and etiology of Parkinson's disease: A review of the evidence. Eur. J. Epidemiol. 2011, 26, S1-S58. [CrossRef,PubMed].
32. Norden, D.M.; Muccigrosso, M.M.; Godbout, J.P. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic cns injury, and neurodegenerative disease. Neuropharmacology 2015, 96, 29-41. [CrossRef,PubMed].
33. Cagnin, A.; Kassiou, M.; Meikle, S.R.; Banati, R.B. In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol. Scand. Suppl. 2006, 185, 107-114. [CrossRef,PubMed].
34. Ferrari, C.C.; Pott Godoy, M.C.; Tarelli, R.; Chertoff, M.; Depino, A.M.; Pitossi, F.J. Progressive neurodegeneration and motor disabilities induced by chronic expression of il-1β in the substantia nigra. Neurobiol. Dis. 2006, 24, 183-193. [CrossRef,PubMed].
35. Novak, M.J.; Tabrizi, S.J. Huntington's disease. BMJ 2010, 340, c3109. [CrossRef,PubMed].
36. Zhao, T.; Hong, Y.; Li, X.J.; Li, S.H. Subcellular clearance and accumulation of huntington disease protein: A mini-review. Front. Mol. Neurosci. 2016, 9, 27. [CrossRef,PubMed].
37. Quarrell, O.; O'Donovan, K.L.; Bandmann, O.; Strong, M. The prevalence of juvenile huntington's disease: A review of the literature and meta-Analysis. PLoS Curr. 2012, 4, e486067423. [CrossRef,PubMed].
38. Rawlins, M.D.; Wexler, N.S.; Wexler, A.R.; Tabrizi, S.J.; Douglas, I.; Evans, S.J.; Smeeth, L. The prevalence of huntington's disease. Neuroepidemiology 2016, 46, 144-153. [CrossRef,PubMed].
39. Wexler, N.S. Huntington's disease: Advocacy driving science. Annu. Rev Med. 2012, 63, 1-22. [CrossRef,PubMed].
40. Hannan, A.J. Novel therapeutic targets for huntington's disease. Expert. Opin. Ther. Targets 2005, 9, 639-650. [CrossRef,PubMed].
41. Ross, C.A.; Aylward, E.H.; Wild, E.J.; Langbehn, D.R.; Long, J.D.; Warner, J.H.; Scahill, R.I.; Leavitt, B.R.; Stout, J.C.; Paulsen, J.S.; et al. Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 2014, 10, 204-216. [CrossRef,PubMed].
42. Chen, C.; Dong, X.P. Epidemiological characteristics of human prion diseases. Infect. Dis. Poverty 2016, 5, 47. [CrossRef,PubMed].
43. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 1998, 95, 13363-13383. [CrossRef,PubMed].
44. National Clinical Guideline Centre (UK). Motor Neurone Disease: Assessment and Management; National Institute for Health and Care Excellence (UK): London, UK, 2016; No. 42.
45. Balendra, R.; Patani, R. Quo vadis motor neuron disease? World J. Methodol. 2016, 6, 56-64. [CrossRef,PubMed].
46. Madill, M.; Fitzgerald, D.; O'Connell, K.E.; Dev, K.K.; Shen, S.; FitzGerald, U. In vitro and ex vivo models of multiple sclerosis. Drug Discov. Today 2016. [CrossRef,PubMed].
47. Watad, A.; Azrielant, S.; Soriano, A.; Bracco, D.; Abu Much, A.; Amital, H. Association between seasonal factors and multiple sclerosis. Eur. J. Epidemiol. 2016. [CrossRef,PubMed].
48. Food and Agricultural Organization of the United Nations. Available online: http://www.fao.org/docrep/006/y5143e/y5143e12.htm (accessed on 28 September 2016).
49. Castillo, J.; Benavente, O.; Delrio, J.A. Naringin and neohesperidin levels during development of leaves, flower buds, and fruits of Citrus-Aurantium. Plant Physiol. 1992, 99, 67-73. [CrossRef,PubMed].
50. Jiang, N.; Doseff, A.I.; Grotewold, E. Flavones: From biosynthesis to health benefits. Plants 2016, 5, 27. [CrossRef,PubMed].
51. Leem, E.; Nam, J.H.; Jeon, M.T.; Shin, W.H.;Won, S.Y.; Park, S.J.; Choi, M.S.; Jin, B.K.; Jung, U.J.; Kim, S.R. Naringin protects the nigrostriatal dopaminergic projection through induction of gdnf in a neurotoxin model of Parkinson's disease. J. Nutr. Biochem. 2014, 25, 801-806. [CrossRef,PubMed].
52. Kim, H.D.; Jeong, K.H.; Jung, U.J.; Kim, S.R. Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system. J. Nutr. Biochem. 2016, 28, 140-146. [CrossRef,PubMed].
53. Gopinath, K.; Sudhandiran, G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 2012, 227, 134-143. [CrossRef,PubMed].
54. Prakash, A.; Shur, B.; Kumar, A. Naringin protects memory impairment and mitochondrial oxidative damage against aluminum-induced neurotoxicity in rats. Int. J. Neurosci. 2013, 123, 636-645. [CrossRef,PubMed].
55. Kumar, A.; Dogra, S.; Prakash, A. Protective effect of naringin, a Citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. J. Med. Food 2010, 13, 976-984. [CrossRef,PubMed].
56. Antunes, M.S.; Goes, A.T.R.; Boeira, S.P.; Prigol, M.; Jesse, C.R. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition 2014, 30, 1415-1422. [CrossRef,PubMed].
57. Menze, E.T.; Tadros, M.G.; Abdel-Tawab, A.M.; Khalifa, A.E. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 2012, 33, 1265-1275. [CrossRef,PubMed].
58. Li, C.Y.; Zug, C.; Qu, H.C.; Schluesener, H.; Zhang, Z.Y. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behav. Brain Res. 2015, 281, 32-42. [CrossRef,PubMed].
59. Wang, D.M.; Liu, L.; Zhu, X.Y.;Wu, W.L.;Wang, Y. Hesperidin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress in a mouse model of Alzheimer's disease. Cell. Mol. Neurobiol. 2014, 34, 1209-1221. [CrossRef,PubMed].
60. Javed, H.; Vaibhav, K.; Ahmed, M.E.; Khan, A.; Tabassum, R.; Islam, F.; Safhi, M.M.; Islam, F. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. J. Neurol. Sci. 2015, 348, 51-59. [CrossRef,PubMed].
61. Thenmozhi, A.J.; Raja, T.R.W.; Janakiraman, U.; Manivasagam, T. Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer's disease in wistar rats. Neurochem. Res. 2015, 40, 767-776. [CrossRef,PubMed].
62. Justin Thenmozhi, A.; William Raja, T.R.; Manivasagam, T.; Janakiraman, U.; Mohamed Essa, M. Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer's disease. Nutr. Neurosci. 2016. [CrossRef,PubMed].
63. Chang, C.Y.; Lin, T.Y.; Lu, C.W.; Huang, S.K.; Wang, Y.C.; Chou, S.S.P.; Wang, S.J. Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats. Neurotoxicology 2015, 50, 157-169. [CrossRef,PubMed].
64. Choi, E.J.; Ahn, W.S. Neuroprotective effects of chronic hesperetin administration in mice. Arch. Pharm. Res. 2008, 31, 1457-1462. [CrossRef,PubMed].
65. Kiasalari, Z.; Khalili, M.; Baluchnejadmojarad, T.; Roghani, M. Protective effect of oral hesperetin against unilateral striatal 6-hydroxydopamine damage in the rat. Neurochem. Res. 2016, 41, 1065-1072. [CrossRef,PubMed].
66. Rainey-Smith, S.; Schroetke, L.W.; Bahia, P.; Fahmi, A.; Skilton, R.; Spencer, J.P.; Rice-Evans, C.; Rattray, M.; Williams, R.J. Neuroprotective effects of hesperetin in mouse primary neurones are independent of creb activation. Neurosci. Lett. 2008, 438, 29-33. [CrossRef,PubMed].
67. Vauzour, D.; Vafeiadou, K.; Rice-Evans, C.; Williams, R.J.; Spencer, J.P. Activation of pro-survival AKT and ERK1/2 signalling pathways underlie the anti-Apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103, 1355-1367. [CrossRef,PubMed].
68. 2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 2008, 56, 859-864. [CrossRef,PubMed].
69. Khan, M.B.; Khan, M.M.; Khan, A.; Ahmed, M.E.; Ishrat, T.; Tabassum, R.; Vaibhav, K.; Ahmad, A.; Islam, F. Naringenin ameliorates Alzheimer's disease (AD)-Type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem. Int. 2012, 61, 1081-1093. [CrossRef,PubMed].
70. Baluchnejadmojarad, T.; Roghani, M. Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: A behavioral analysis. Pharmacology 2006, 78, 193-197. [CrossRef,PubMed].
71. Heo, H.J.; Kim, D.O.; Shin, S.C.; Kim, M.J.; Kim, B.G.; Shin, D.H. Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection. J. Agric. Food Chem. 2004, 52, 1520-1525. [CrossRef,PubMed].
72. Wu, L.H.; Lin, C.; Lin, H.Y.; Liu, Y.S.; Wu, C.Y.J.; Tsai, C.F.; Chang, P.C.; Yeh, W.L.; Lu, D.Y. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression. Mol. Neurobiol. 2016, 53, 1080-1091. [CrossRef,PubMed].
73. Vafeiadou, K.; Vauzour, D.; Lee, H.Y.; Rodriguez-Mateos, A.;Williams, R.J.; Spencer, J.P. The Citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484, 100-109. [CrossRef,PubMed].
74. Morelli, S.; Piscioneri, A.; Salerno, S.; Al-Fageeh, M.B.; Drioli, E.; de Bartolo, L. Neuroprotective effect of didymin on hydrogen peroxide-induced injury in the neuronal membrane system. Cells Tissues Organs 2014, 199, 184-200. [CrossRef,PubMed].
75. Choi, B.S.; Sapkota, K.; Kim, S.; Lee, H.J.; Choi, H.S.; Kim, S.J. Antioxidant activity and protective effects of Tripterygium regelii extract on hydrogen peroxide-induced injury in human dopaminergic cells, SH-SY5Y. Neurochem. Res. 2010, 35, 1269-1280. [CrossRef,PubMed].
76. Rong, W.; Wang, J.; Liu, X.; Jiang, L.; Wei, F.; Hu, X.; Han, X.; Liu, Z. Naringin treatment improves functional recovery by increasing bdnf and vegf expression, inhibiting neuronal apoptosis after spinal cord injury. Neurochem. Res. 2012, 37, 1615-1623. [CrossRef,PubMed].
77. Golechha, M.; Chaudhry, U.; Bhatia, J.; Saluja, D.; Arya, D.S. Naringin protects against kainic acid-induced status epilepticus in rats: Evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull. 2011, 34, 360-365. [CrossRef,PubMed].
78. Brouillet, E.; Jacquard, C.; Bizat, N.; Blum, D. 3-Nitropropionic acid: A mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in huntington's disease. J. Neurochem. 2005, 95, 1521-1540. [CrossRef,PubMed].
79. Parhiz, H.; Roohbakhsh, A.; Soltani, F.; Rezaee, R.; Iranshahi, M. Antioxidant and anti-inflammatory properties of the Citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother. Res. 2015, 29, 323-331. [CrossRef,PubMed].
80. Youdim, K.A.; Dobbie, M.S.; Kuhnle, G.; Proteggente, A.R.; Abbott, N.J.; Rice-Evans, C. Interaction between flavonoids and the blood-brain barrier: In vitro studies. J. Neurochem. 2003, 85, 180-192. [CrossRef,PubMed].
81. Herrmann, N.; Chau, S.A.; Kircanski, I.; Lanctot, K.L. Current and emerging drug treatment options for Alzheimer's disease a systematic review. Drugs 2011, 71, 2031-2065. [CrossRef,PubMed].
82. Chin-Chan, M.; Navarro-Yepes, J.; Quintanilla-Vega, B. Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front. Cell. Neurosci. 2015, 9, 124. [CrossRef,PubMed].
83. Mehta, A.; Prabhakar, M.; Kumar, P.; Deshmukh, R.; Sharma, P.L. Excitotoxicity: Bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 2013, 698, 6-18. [CrossRef,PubMed].
84. Lau, A.; Tymianski, M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflug. Arch. Eur. J. Phy. 2010, 460, 525-542. [CrossRef,PubMed].
85. De la Monte, S.M.; Tong, M. Mechanisms of nitrosamine-mediated neurodegeneration: Potential relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 2009, 17, 817-825. [PubMed].
86. Lester-Coll, N.; Rivera, E.J.; Soscia, S.J.; Doiron, K.;Wands, J.R.; de la Monte, S.M. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 2006, 9, 13-33. [PubMed].
87. Choi, A.Y.; Choi, J.H.; Lee, J.Y.; Yoon, K.S.; Choe, W.; Ha, J.; Yeo, E.J.; Kang, I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem. Int. 2010, 57, 143-152. [CrossRef,PubMed].
88. Braidy, N.; Grant, R.; Adams, S.; Guillemin, G.J. Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J. 2010, 277, 368-382. [CrossRef,PubMed].
89. Losi, G.; Puia, G.; Garzon, G.; de Vuono, M.C.; Baraldi, M. Apigenin modulates gabaergic and glutamatergic transmission in cultured cortical neurons. Eur. J. Pharmacol. 2004, 502, 41-46. [CrossRef,PubMed].
90. Zhao, L.;Wang, J.L.; Liu, R.; Li, X.X.; Li, J.F.; Zhang, L. Neuroprotective, anti-Amyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model. Molecules 2013, 18, 9949-9965. [CrossRef,PubMed].
91. Liu, R.; Zhang, T.T.; Yang, H.G.; Lan, X.; Ying, J.A.; Du, G.H. The flavonoid apigenin protects brain neurovascular coupling against amyloid-β(25-35)-induced toxicity in mice. J. Alzheimers Dis. 2011, 24, 85-100. [PubMed].
92. Popovic, M.; Caballero-Bleda, M.; Benavente-Garcia, O.; Castillo, J. The flavonoid apigenin delays forgetting of passive avoidance conditioning in rats. J. Psychopharmacol. 2014, 28, 498-501. [CrossRef,PubMed].
93. Taupin, P. Apigenin and related compounds stimulate adult neurogenesis. Mars, inc., the salk institute for biological studies: Wo2008147483. Expert Opin Ther. Pat. 2009, 19, 523-527. [CrossRef,PubMed].
94. Patil, C.S.; Singh, V.P.; Satyanarayan, P.S.V.; Jain, N.K.; Singh, A.; Kulkarni, S.K. Protective effect of flavonoids against aging-And lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 2003, 69, 59-67. [CrossRef,PubMed].
95. Patil, S.P.; Jain, P.D.; Sancheti, J.S.; Ghumatkar, P.J.; Tambe, R.; Sathaye, S. Neuroprotective and neurotrophic effects of apigenin and luteolin in mptp induced Parkinsonism in mice. Neuropharmacology 2014, 86, 192-202. [CrossRef,PubMed].
96. Liu, W.H.; Kong, S.Z.; Xie, Q.F.; Su, J.Y.; Li, W.J.; Guo, H.Z.; Li, S.S.; Feng, X.X.; Su, Z.R.; Xu, Y.; et al. Protective effects of apigenin against 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Int. J. Mol. Med. 2015, 35, 739-746. [CrossRef,PubMed].
97. Wu, P.S.; Yen, J.H.; Kou, M.C.; Wu, M.J. Luteolin and apigenin attenuate 4-hydroxy-2-nonenal-mediated cell death through modulation of UPR, Nrf2-ARE and MAPK pathways in PC12 cells. PLoS ONE 2015, 10, e0130599. [CrossRef,PubMed].
98. Fu, X.B.; Zhang, J.Z.; Guo, L.; Xu, Y.G.; Sun, L.Y.; Wang, S.S.; Feng, Y.; Gou, L.S.; Zhang, L.; Liu, Y. Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats. Pharmacol. Biochem. Behav. 2014, 126, 122-130. [CrossRef,PubMed].
99. Xu, B.; Li, X.X.; He, G.R.; Hu, J.J.; Mu, X.; Tian, S.; Du, G.H. Luteolin promotes long-Term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 2010, 627, 99-105. [CrossRef,PubMed].
100. Liu, Y.; Fu, X.B.; Lan, N.; Li, S.; Zhang, J.Z.; Wang, S.S.; Li, C.; Shang, Y.G.; Huang, T.H.; Zhang, L. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav. Brain Res. 2014, 267, 178-188. [CrossRef,PubMed].
101. Wang, H.M.; Wang, H.L.; Cheng, H.X.; Che, Z.Y. Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model. Mol. Med. Rep. 2016, 13, 4215-4220. [CrossRef,PubMed].
102. Hu, L.W.; Yen, J.H.; Shen, Y.T.; Wu, K.Y.; Wu, M.J. Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells. PLoS ONE 2014, 9, e97880. [CrossRef,PubMed].
103. Wruck, C.J.; Claussen, M.; Fuhrmann, G.; Romer, L.; Schulz, A.; Pufe, T.; Waetzig, V.; Peipp, M.; Herdegen, T.; Gotz, M.E. Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keapl-Nrf2-ARE pathway. J. Neural. Transm. Suppl. 2007, 72, 57-67. [PubMed].
104. Rezai-Zadeh, K.; Ehrhart, J.; Bai, Y.; Sanberg, P.R.; Bickford, P.; Tan, J.; Shytle, R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflamm. 2008, 5. [CrossRef,PubMed].
105. Rezai-Zadeh, K.; Shytle, R.D.; Bai, Y.; Tian, J.; Hou, H.Y.; Mori, T.; Zeng, J.; Obregon, D.; Town, T.; Tan, J. Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-Amyloid production. J. Cell. Mol. Med. 2009, 13, 574-588. [CrossRef,PubMed].
106. Kao, T.K.; Ou, Y.C.; Lin, S.Y.; Pan, H.C.; Song, P.J.; Raung, S.L.; Lai, C.Y.; Liao, S.L.; Lu, H.C.; Chen, C.J. Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 2011, 22, 612-624. [CrossRef,PubMed].
107. Chen, H.Q.; Jin, Z.Y.;Wang, X.J.; Xua, X.M.; Deng, L.; Zhao, J.W. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci. Lett. 2008, 448, 175-179. [CrossRef,PubMed].
108. Zhu, L.H.; Bi, W.; Qi, R.B.; Wang, H.D.; Lu, D.X. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int. J. Neurosci. 2011, 121, 329-336. [CrossRef,PubMed].
109. Zhu, L.H.; Bi, W.; Lu, D.; Zhang, C.J.; Shu, X.M.; Lu, D.X. Luteolin inhibits SH-SY5Y cell apoptosis through suppression of the nuclear transcription factor-κB, mitogen-Activated protein kinase and protein kinase B pathways in lipopolysaccharide-stimulated cocultured BV2 cells. Exp. Ther. Med. 2014, 7, 1065-1070. [CrossRef,PubMed].
110. Dirscherl, K.; Karlstetter, M.; Ebert, S.; Kraus, D.; Hlawatsch, J.; Walczak, Y.; Moehle, C.; Fuchshofer, R.; Langmann, T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J. Neuroinflamm. 2010, 7. [CrossRef,PubMed].
111. Nabavi, S.F.; Braidy, N.; Gortzi, O.; Sobarzo-Sanchez, E.; Daglia, M.; Skalicka-Wozniak, K.; Nabavi, S.M. Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. Brain Res. Bull. 2015, 119, 1-11. [CrossRef,PubMed].
112. Chao, C.C.; Hu, S.X. Tumor-necrosis-factor-Alpha potentiates glutamate neurotoxicity in human fetal brain-cell cultures. Dev. Neurosci. 1994, 16, 172-179. [CrossRef,PubMed].
113. Le, W.D.; Rowe, D.; Xie, W.J.; Ortiz, I.; He, Y.; Appel, S.H. Microglial activation and dopaminergic cell injury: An in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21, 8447-8455. [PubMed].
114. Park, S.E.; Sapkota, K.; Kim, S.; Kim, H.; Kim, S.J. Kaempferol acts through mitogen-Activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. Br. J. Pharmacol. 2011, 164, 1008-1025. [CrossRef,PubMed].
115. Yang, E.J.; Kim, G.S.; Jun, M.; Song, K.S. Kaempferol attenuates the glutamate-induced oxidative stress in mouse-derived hippocampal neuronal HT22 cells. Food Funct. 2014, 5, 1395-1402. [CrossRef,PubMed].
116. Magalingam, K.B.; Radhakrishnan, A.; Haleagrahara, N. Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int. J. Mol. Med. 2013, 32, 235-240. [PubMed].
117. Song, K.; Kim, S.; Na, J.Y.; Park, J.H.; Kim, J.K.; Kim, J.H.; Kwon, J. Rutin attenuates ethanol-induced neurotoxicity in hippocampal neuronal cells by increasing aldehyde dehydrogenase 2. Food Chem. Toxicol. 2014, 72, 228-233. [CrossRef,PubMed].
118. Yu, X.L.; Li, Y.N.; Zhang, H.; Su, Y.J.; Zhou, W.W.; Zhang, Z.P.;Wang, S.W.; Xu, P.X.;Wang, Y.J.; Liu, R.T. Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress. Food Funct. 2015, 6, 3296-3306. [CrossRef,PubMed].
119. Na, J.Y.; Kim, S.; Song, K.; Kwon, J. Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells. Cell. Mol. Neurobiol. 2014, 34, 1071-1079. [CrossRef,PubMed].
120. Nassiri-Asl, M.; Naserpour Farivar, T.; Abbasi, E.; Sadeghnia, H.R.; Sheikhi, M.; Lotfizadeh, M.; Bazahang, P. Effects of rutin on oxidative stress in mice with kainic acid-induced seizure. J. Integr. Med. 2013, 11, 337-342. [CrossRef,PubMed].
121. Khan, M.M.; Raza, S.S.; Javed, H.; Ahmad, A.; Khan, A.; Islam, F.; Safhi, M.M.; Islam, F. Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurotox. Res. 2012, 22, 1-15. [CrossRef,PubMed].
122. Wang, S.W.;Wang, Y.J.; Su, Y.J.; Zhou, W.W.; Yang, S.G.; Zhang, R.; Zhao, M.; Li, Y.N.; Zhang, Z.P.; Zhan, D.W.; et al. Rutin inhibits β-Amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 2012, 33, 482-490. [CrossRef,PubMed].
123. Xu, P.X.; Wang, S.W.; Yu, X.L.; Su, Y.J.; Wang, T.; Zhou, W.W.; Zhang, H.; Wang, Y.J.; Liu, R.T. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing abeta oligomer level and attenuating oxidative stress and neuroinflammation. Behav. Brain Res. 2014, 264, 173-180. [CrossRef,PubMed].
124. Machawal, L.; Kumar, A. Possible involvement of nitric oxide mechanism in the neuroprotective effect of rutin against immobilization stress induced anxiety like behaviour, oxidative damage in mice. Pharmacol. Rep. 2014, 66, 15-21. [CrossRef,PubMed].
125. Moghbelinejad, S.; Nassiri-Asl, M.; Farivar, T.N.; Abbasi, E.; Sheikhi, M.; Taghiloo, M.; Farsad, F.; Samimi, A.; Hajiali, F. Rutin activates the MAPK pathway and BDNF gene expression on beta-Amyloid induced neurotoxicity in rats. Toxicol. Lett. 2014, 224, 108-113. [CrossRef,PubMed].
126. Habtemariam, S. Rutin as a natural therapy for Alzheimer's disease: Insights into its mechanisms of action. Curr. Med. Chem. 2016, 23, 860-873. [CrossRef,PubMed].
127. Jesberger, J.A.; Richardson, J.S. Oxygen free-radicals and brain-dysfunction. Int. J. Neurosci. 1991, 57, 1-17. [CrossRef,PubMed].
128. Shin, H.J.; Lee, J.Y.; Son, E.; Lee, D.H.; Kim, H.J.; Kang, S.S.; Cho, G.J.; Choi, W.S.; Roh, G.S. Curcumin attenuates the kainic acid-induced hippocampal cell death in the mice. Neurosci. Lett. 2007, 416, 49-54. [CrossRef,PubMed].
129. Suematsu, N.; Hosoda, M.; Fujimori, K. Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells. Neurosci. Lett. 2011, 504, 223-227. [CrossRef,PubMed].
130. Roshanzamir, F.; Yazdanparast, R. Quercetin attenuates cell apoptosis of oxidant-stressed SK-N-MC cells while suppressing up-regulation of the defensive element, HIF-1α. Neuroscience 2014, 277, 780-793. [CrossRef,PubMed].
131. Jembrek, M.J.; Vukovic, L.; Puhovic, J.; Erhardt, J.; Orsolic, N. Neuroprotective effect of quercetin against hydrogen peroxide-induced oxidative injury in P19 neurons. J. Mol. Neurosci. 2012, 47, 286-299. [CrossRef,PubMed].
132. Sajad, M.; Zargan, J.; Zargar, M.A.; Sharma, J.; Umar, S.; Arora, R.; Khan, H.A. Quercetin prevents protein nitration and glycolytic block of proliferation in hydrogen peroxide insulted cultured neuronal precursor cells (NPCS): Implications on cns regeneration. Neurotoxicology 2013, 36, 24-33. [CrossRef,PubMed].
133. Ansari, M.A.; Abdul, H.M.; Joshi, G.; Opii, W.O.; Butterfield, D.A. Protective effect of quercetin in primary neurons against Aβ(1-42): Relevance to Alzheimer's disease. J. Nutr. Biochem. 2009, 20, 269-275. [CrossRef,PubMed].
134. Zhang, X.; Hu, J.; Zhong, L.; Wang, N.; Yang, L.; Liu, C.C.; Li, H.; Wang, X.; Zhou, Y.; Zhang, Y.; et al. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice. Neuropharmacology 2016, 108, 179-192. [CrossRef,PubMed].
135. Lv, C.; Hong, T.; Yang, Z.; Zhang, Y.; Wang, L.; Dong, M.; Zhao, J.; Mu, J.; Meng, Y. Effect of quercetin in the 1-methyl-4-phenyl-1, 2, 3, 6-Tetrahydropyridine-induced mouse model of Parkinson's disease. Evid. Based Complement. Altern. Med. 2012, 2012, 928643. [CrossRef,PubMed].
136. Chen, J.C.; Ho, F.M.; Pei-Dawn Lee, C.; Chen, C.P.; Jeng, K.C.; Hsu, H.B.; Lee, S.T.; Wen Tung, W.; Lin, W.W. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IκB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse Bv-2 microglia. Eur. J. Pharmacol. 2005, 521, 9-20. [CrossRef,PubMed].
137. Kang, C.H.; Choi, Y.H.; Moon, S.K.; Kim, W.J.; Kim, G.Y. Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-κB pathway and activating the Nrf2-dependent HO-1 pathway. Int. Immunopharmacol. 2013, 17, 808-813. [CrossRef,PubMed].
138. Bournival, J.; Francoeur, M.A.; Renaud, J.; Martinoli, M.G. Quercetin and sesamin protect neuronal PC12 cells from high-glucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 2012, 15, 322-333. [CrossRef,PubMed].
139. Xia, S.F.; Xie, Z.X.; Qiao, Y.; Li, L.R.; Cheng, X.R.; Tang, X.; Shi, Y.H.; Le, G.W. Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress. Physiol. Behav. 2015, 138, 325-331. [CrossRef,PubMed].
140. Lu, J.; Wu, D.M.; Zheng, Y.L.; Hu, B.; Zhang, Z.F.; Shan, Q.; Zheng, Z.H.; Liu, C.M.; Wang, Y.J. Quercetin activates AMP-Activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J. Pathol. 2010, 222, 199-212. [CrossRef,PubMed].
141. Zhang, Y.; Yi, B.; Ma, J.; Zhang, L.; Zhang, H.; Yang, Y.; Dai, Y. Quercetin promotes neuronal and behavioral recovery by suppressing inflammatory response and apoptosis in a rat model of intracerebral hemorrhage. Neurochem. Res. 2015, 40, 195-203. [CrossRef,PubMed].
142. Arikan, S.; Ersan, I.; Karaca, T.; Kara, S.; Gencer, B.; Karaboga, I.; Hasan Ali, T. Quercetin protects the retina by reducing apoptosis due to ischemia-reperfusion injury in a rat model. Arq. Bras. Oftalmol. 2015, 78, 100-104. [CrossRef,PubMed].
143. Tota, S.; Awasthi, H.; Kamat, P.K.; Nath, C.; Hanif, K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav. Brain Res. 2010, 209, 73-79. [CrossRef,PubMed].
144. Richetti, S.K.; Blank, M.; Capiotti, K.M.; Piato, A.L.; Bogo, M.R.; Vianna, M.R.; Bonan, C.D. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav. Brain Res. 2011, 217, 10-15. [CrossRef,PubMed].
145. Hu, P.; Wang, M.; Chen, W.H.; Liu, J.; Chen, L.; Yin, S.T.; Yong, W.; Chen, J.T.; Wang, H.L.; Ruan, D.Y. Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 2008, 378, 43-51. [CrossRef,PubMed].
146. Barcelos, G.R.; Grotto, D.; Serpeloni, J.M.; Angeli, J.P.; Rocha, B.A.; de Oliveira Souza, V.C.; Vicentini, J.T.; Emanuelli, T.; Bastos, J.K.; Antunes, L.M.; et al. Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats. Arch. Toxicol. 2011, 85, 1151-1157. [CrossRef,PubMed].
147. Sachdeva, S.; Pant, S.C.; Kushwaha, P.; Bhargava, R.; Flora, S.J. Sodium tungstate induced neurological alterations in rat brain regions and their response to antioxidants. Food Chem. Toxicol. 2015, 82, 64-71. [CrossRef,PubMed].
148. Sharma, D.R.; Wani, W.Y.; Sunkaria, A.; Kandimalla, R.J.; Verma, D.; Cameotra, S.S.; Gill, K.D. Quercetin protects against chronic aluminum-induced oxidative stress and ensuing biochemical, cholinergic, and neurobehavioral impairments in rats. Neurotox. Res. 2013, 23, 336-357. [CrossRef,PubMed].
149. Sharma, D.R.; Sunkaria, A.;Wani, W.Y.; Sharma, R.K.; Verma, D.; Priyanka, K.; Bal, A.; Gill, K.D. Quercetin protects against aluminium induced oxidative stress and promotes mitochondrial biogenesis via activation of the PGC-1α signaling pathway. Neurotoxicology 2015, 51, 116-137. [CrossRef,PubMed].
150. Sharma, D.R.; Wani, W.Y.; Sunkaria, A.; Kandimalla, R.J.; Sharma, R.K.; Verma, D.; Bal, A.; Gill, K.D. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience 2016, 324, 163-176. [CrossRef,PubMed].
151. Bavithra, S.; Selvakumar, K.; Pratheepa Kumari, R.; Krishnamoorthy, G.; Venkataraman, P.; Arunakaran, J. Polychlorinated biphenyl (PCBs)-induced oxidative stress plays a critical role on cerebellar dopaminergic receptor expression: Ameliorative role of quercetin. Neurotox. Res. 2012, 21, 149-159. [CrossRef,PubMed].
152. Selvakumar, K.; Bavithra, S.; Ganesh, L.; Krishnamoorthy, G.; Venkataraman, P.; Arunakaran, J. Polychlorinated biphenyls induced oxidative stress mediated neurodegeneration in hippocampus and behavioral changes of adult rats: Anxiolytic-like effects of quercetin. Toxicol. Lett. 2013, 222, 45-54. [CrossRef,PubMed].
153. Beckmann, D.V.; Carvalho, F.B.; Mazzanti, C.M.; Dos Santos, R.P.; Andrades, A.O.; Aiello, G.; Rippilinger, A.; Graca, D.L.; Abdalla, F.H.; Oliveira, L.S.; et al. Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide. Life Sci. 2014, 103, 79-87. [CrossRef,PubMed].
154. Nassiri-Asl, M.; Moghbelinejad, S.; Abbasi, E.; Yonesi, F.; Haghighi, M.R.; Lotfizadeh, M.; Bazahang, P. Effects of quercetin on oxidative stress and memory retrieval in kindled rats. Epilepsy Behav. 2013, 28, 151-155. [CrossRef,PubMed].
155. Datla, K.P.; Christidou, M.;Widmer, W.W.; Rooprai, H.K.; Dexter, D.T. Tissue distribution and neuroprotective effects of Citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 2001, 12, 3871-3875. [CrossRef,PubMed].
156. Shu, Z.P.; Yang, B.Y.; Zhao, H.; Xu, B.Q.; Jiao, W.J.;Wang, Q.H.;Wang, Z.B.; Kuang, H.X. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells. Int. Immunopharmacol. 2014, 19, 275-282. [CrossRef,PubMed].
157. Matsuzaki, K.; Yamakuni, T.; Hashimoto, M.; Haque, A.M.; Shido, O.; Mimaki, Y.; Sashida, Y.; Ohizumi, Y. Nobiletin restoring β-Amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats. Neurosci. Lett. 2006, 400, 230-234. [CrossRef,PubMed].
158. Onozuka, H.; Nakajima, A.; Matsuzaki, K.; Shin, R.W.; Ogino, K.; Saigusa, D.; Tetsu, N.; Yokosuka, A.; Sashida, Y.; Mimaki, Y.; et al. Nobiletin, a Citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 2008, 326, 739-744. [CrossRef,PubMed].
159. Nakajima, A.; Aoyama, Y.; Nguyen, T.T.; Shin, E.J.; Kim, H.C.; Yamada, S.; Nakai, T.; Nagai, T.; Yokosuka, A.;Mimaki, Y.; et al. Nobiletin, a Citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-Accelerated mouse. Behav. Brain Res. 2013, 250, 351-360. [CrossRef,PubMed].
160. Nakajima, A.; Aoyama, Y.; Shin, E.J.; Nam, Y.; Kim, H.C.; Nagai, T.; Yokosuka, A.; Mimaki, Y.; Yokoi, T.; Ohizumi, Y.; et al. Nobiletin, a Citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behav. Brain Res. 2015, 289, 69-77. [CrossRef,PubMed].
161. Yamakuni, T.; Nakajima, A.; Ohizumi, Y. Preventive action of nobiletin, a constituent of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, against amyloid-beta peptide-induced neurotoxicity expression and memory impairment. Yakugaku Zasshi 2010, 130, 517-520. [CrossRef,PubMed].
162. Jeong, K.H.; Jeon, M.T.; Kim, H.D.; Jung, U.J.; Jang, M.C.; Chu, J.W.; Yang, S.J.; Choi, I.Y.; Choi, M.S.; Kim, S.R. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-Treated rat model of Parkinson's disease. J. Med. Food 2015, 18, 409-414. [CrossRef,PubMed].
163. Cui, Y.;Wu, J.; Jung, S.C.; Park, D.B.; Maeng, Y.H.; Hong, J.Y.; Kim, S.J.; Lee, S.R.; Kim, S.J.; Kim, S.J.; et al.Anti-neuroinflammatory activity of nobiletin on suppression of microglial activation. Biol. Pharm. Bull. 2010, 33, 1814-1821. [CrossRef,PubMed].
164. Yamamoto, Y.; Shioda, N.; Han, F.; Moriguchi, S.; Nakajima, A.; Yokosuka, A.; Mimaki, Y.; Sashida, Y.; Yamakuni, T.; Ohizumi, Y.; et al. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res. 2009, 1295, 218-229. [CrossRef,PubMed].
165. Zhang, L.; Zhang, X.; Zhang, C.; Bai, X.; Zhang, J.; Zhao, X.; Chen, L.; Wang, L.; Zhu, C.; Cui, L.; et al. Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo. Brain Res. 2016, 1636, 130-141. [CrossRef,PubMed].